Federated Hermes’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-83
Closed -$237 2066
2025
Q1
$237 Sell
83
-18
-18% -$80 ﹤0.01% 2038
2024
Q4
$595 Sell
101
-1,405
-93% -$7.93K ﹤0.01% 2037
2024
Q3
$6.72K Sell
1,506
-21
-1% -$493 ﹤0.01% 1834
2024
Q2
$40.5K Buy
1,527
+67
+5% +$1.58K ﹤0.01% 1634
2024
Q1
$40K Buy
1,460
+55
+4% +$1.75K ﹤0.01% 1634
2023
Q4
$34.1K Sell
1,405
-88
-6% -$1.56K ﹤0.01% 1691
2023
Q3
$30.2K Sell
1,493
-473
-24% -$12.1K ﹤0.01% 1732
2023
Q2
$58K Buy
1,966
+908
+86% +$25.9K ﹤0.01% 1658
2023
Q1
$26.5K Buy
1,058
+399
+61% +$12.8K ﹤0.01% 1790
2022
Q4
$20.9K Buy
659
+329
+100% +$10.4K ﹤0.01% 1800
2022
Q3
$10K Buy
330
+261
+378% +$9.01K ﹤0.01% 1830
2022
Q2
$2K Buy
+69
New +$6.32K ﹤0.01% 1964

Other funds holding LONA

Federated Hermes's LONA Position: Q2 2025 in Review

Federated Hermes sold out of LeonaBio Inc (LONA) in Q2 2025, closing a stake of 83 shares — an estimated $237 sold.

Federated Hermes first reported a position in LONA in Q2 2022 and held it in 12 quarters. The position peaked at $58K in Q2 2023. 50 funds tracked by Wall St. Rank hold LONA as of Q2 2025.

  • Federated Hermes reported no remaining LeonaBio Inc position as of Q2 2025 after selling out during the quarter.
  • Federated Hermes sold 83 LeonaBio Inc shares in Q2 2025, an estimated $237.
  • Federated Hermes first reported a position in LeonaBio Inc in Q2 2022 and held it in 12 quarters.
  • Federated Hermes's LeonaBio Inc position peaked at $58K in Q2 2023.
  • 50 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2025.

Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.